An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Hoofdauteur: | Bristy, Israt Zerin |
---|---|
Andere auteurs: | Kabir, Md. Tanvir |
Formaat: | Thesis |
Taal: | English |
Gepubliceerd in: |
Brac University
2021
|
Onderwerpen: | |
Online toegang: | http://hdl.handle.net/10361/15619 |
Gelijkaardige items
-
Molecules associated with the development of lung cancer
door: Rahman, Adree, et al.
Gepubliceerd in: (2023) -
A case study of lung cancer patients in term of various risk factors in context of Bangladesh
door: Shabnam, Musharrat
Gepubliceerd in: (2018) -
Immunotherapy in the Management of Lung Cancer
door: Tasnim, Humayra
Gepubliceerd in: (2022) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
door: Paul, Pulock
Gepubliceerd in: (2024) -
Potential of liposomes for the treatment of lung cancer- a review
door: Mim, Shanzida
Gepubliceerd in: (2023)